SCHEMBL1490324

SCHEMBL1490324

CCCCCCCCCCCCCCCCOC(=O)C(C)(C)CCCCCC

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 1/20 0.58
CYP4A11 Q02928 1/20 0.58
NAAA Q02083 1/20 0.52
EPHX1 P07099 1/20 0.48
TSHR P16473 3/20 0.47
HCAR2 Q8TDS4 1/20 0.44
RAD52 P43351 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
ELANE P08246 1/20 0.44
MEN1 O00255 1/20 0.44
MAPT P10636 1/20 0.44
KMT2A Q03164 1/20 0.44
ATM Q13315 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
FAAH O00519 1/20 0.43
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43
ACHE P22303 5/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27578131 1.00 CYP4F2 (0.58) CYP4F2CYP4A11NAAAEPHX1TSHR
SCHEMBL11319928 1.00 CYP4F2 (0.58) CYP4F2CYP4A11NAAAEPHX1TSHR
SCHEMBL28673377 1.00 CYP4F2 (0.58) CYP4F2CYP4A11NAAAEPHX1TSHR
SCHEMBL26959215 1.00 CYP4F2 (0.58) CYP4F2CYP4A11NAAAEPHX1TSHR
SCHEMBL4809521 1.00 CYP4F2 (0.58) CYP4F2CYP4A11NAAAEPHX1TSHR
SCHEMBL4809511 1.00 CYP4F2 (0.58) CYP4F2CYP4A11NAAAEPHX1TSHR
SCHEMBL23581670 1.00 CYP4F2 (0.58) CYP4F2CYP4A11NAAAEPHX1TSHR
SCHEMBL6686460 1.00 CYP4F2 (0.58) CYP4F2CYP4A11NAAAEPHX1TSHR
SCHEMBL29146085 1.00 CYP4F2 (0.58) CYP4F2CYP4A11NAAAEPHX1TSHR
Ammonia Solution, Strong SCHEMBL22775979 0.98 CYP4F2 (0.56) CYP4F2CYP4A11NAAAEPHX1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119015394-A Sulfur-containing compound preparation, and preparation method and application thereof 上海优斐斯生物科技有限公司 2024-11-26 CN claimed
EP-3513786-B1 LAMINATE PATCHABLE A LIVING BODY NITTO DENKO CORP (JP) 2025-07-09 EP disclosed
CN-114173744-B Solid cosmetic 株式会社资生堂 2025-05-09 CN disclosed
CN-119015394-A Sulfur-containing compound preparation, and preparation method and application thereof 上海优斐斯生物科技有限公司 2024-11-26 CN disclosed
CN-118201590-A Cosmetic product 株式会社资生堂 2024-06-14 CN disclosed
CN-117897131-A Method for producing film 花王株式会社 2024-04-16 CN disclosed
US-20240050339-A1 FORMULATION COMPRISING P-MENTHANE-3,8-DIOL MAZE GREEN LIMITED (GB) 2024-02-15 US disclosed
CN-114173755-B Oily cosmetic 株式会社资生堂 2024-02-06 CN disclosed
US-20240024223-A1 FIBER-FORMING COMPOSITION KAO CORPORATION (JP) 2024-01-25 US disclosed
US-11806414-B2 Silica-including microcapsule resin particles, method for producing same, and application thereof SEKISUI PLASTICS CO., LTD. (JP) 2023-11-07 US disclosed
US-20100008957-A1 FORMULATIONS HAVING IMPROVED COMPATIBILITY WITH NONWOVEN SUBSTRATES KIMBERLY-CLARK WORLDWIDE, INC. (US) 2010-01-14 US disclosed
US-20100008958-A1 SUBSTRATES HAVING FORMULATIONS WITH IMPROVED TRANSFERABILITY KIMBERLY-CLARK WORLDWIDE, INC. (US) 2010-01-14 US disclosed
WO-2010001293-A2 SPRAYABLE SKIN PROTECTANT FORMULATION AND METHOD OF USE KIMBERLY-CLARK WORLDWIDE, INC. (US) 2010-01-07 WO disclosed
US-20090324506-A1 Sprayable skin protectant formulation and method of use KIMBERLY-CLARK WORLDWIDE, INC. 2009-12-31 US disclosed
EP-2099530-A1 UV ABSORBER FORMULATIONS Ciba Holding Inc. (CH) 2009-09-16 EP disclosed
US-20090196894-A1 Self Tanning Composition CIBA CORP. 2009-08-06 US disclosed
EP-2026746-A2 SELF TANNING COMPOSITION Ciba Holding Inc. (CH) 2009-02-25 EP disclosed
WO-2009016064-A1 USE OF NANODISPERSIONS TO PROTECT WATER-SOLUBLE INGREDIENTS IN COSMETIC END FORMULATIONS BASF SE (CH) 2009-02-05 WO disclosed
WO-2008080892-A1 UV ABSORBER FORMULATIONS CIBA HOLDING INC. (CH) 2008-07-10 WO disclosed
WO-2007137958-A2 SELF TANNING COMPOSITION CIBA HOLDING INC. (CH) 2007-12-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090196894-A1 Self Tanning Composition C9, KRT18, F12 CYP4F2 2784/4885CYP4A11 3185/4885NAAA 3767/4885
US-20240050339-A1 FORMULATION COMPRISING P-MENTHANE-3,8-DIOL MPDU1, GMDS, SORD CYP4F2 3042/4885CYP4A11 1058/4885NAAA 2063/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.